We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · May 10, 2022

Initial Decline in eGFR After Dapagliflozin Initiation and Its Associated Outcomes in Patients With HFrEF



Additional Info

Disclosure statements are available on the authors' profiles:

Initial Decline ("dip") in Estimated Glomerular Filtration Rate Following Initiation of Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: Insights from DAPA-HF
Circulation 2022 Apr 20;[EPub Ahead of Print], C Adamson, KF Docherty, HJL Heerspink, RA de Boer, K Damman, SE Inzucchi, L Køber, MN Kosiborod, FA Martinez, MC Petrie, P Ponikowski, MS Sabatine, M Schou, SD Solomon, S Verma, O Bengtsson, AM Langkilde, M Sjöstrand, M Vaduganathan, PS Jhund, JJV McMurray

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading